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Figure 1. Schematic Representation of FGFR Mutants
The wild-type receptor (XFR) contains a signal sequence (black box), three extracellular immunoglobulin loops, a transmembrane domain (hatched box), and a split intracellular tyrosine kinase domain (gray boxes). The dominant negative construct, XFD, lacks the tyrosine kinase domain (deletion at amino acid 398) (see arrowhead). D48 encodes a nonfunctional FGFR and, in addition to an intracellular deletion, has an extracellular deletion of 48 amino acids (between amino acids 125 and 173) that removes the acid box (white box) and the three amino acid HAV sequence (Histidine, Alanine, Valine), but retains a cysteine at position 174, possibly critical for protein folding. HAVφ is identical to XFD except for a 3 amino acid deletion of the HAV sequence. This construct does not act as a dominant Figure 2 . RGCs Expressing Dominant Negative FGFR Initiate Axons negative for FGF signaling, but does function as a dominant negative RGCs in 50-m thick vibratome sections of the eye of stage 40 for a novel non-FGF ligand of the FGFR (Kinoshita et al., 1995) .
Xenopus embryos transfected at stage 19. ase reporter construct (CS2-Luc) (Holt et al., 1990; Lilienbaum et al., 1995) and two nonfunctional FGFR mutants, D48 and HAVφ, were used to transfect RGCs immunostained in wholemount, and transfected cells and their axons were analyzed in serial vibratome sec- (Figure 1 ). In addition to a large intracellular deletion, D48 contains a 48 amino acid deletion, and HAVφ contains a tions through the eye and the brain. Luciferase-expressing cells were visualized with an anti-luciferase antibody three amino acid deletion (Histidine, Alanine, Valine) (HAV) in the extracellular domain of the receptor (Amaya (Holt et al., 1990 ) ( Figure 2C ), whereas an anti-Xenopus FGFR antibody (Amaya et al., 1993 (Amaya et al., ) was used to visualize et al., 1991 (Amaya et al., , 1993 . HAVφ and D48 are unable to mediate FGF binding and receptor dimerization; therefore, they cells expressing the three FGFR constructs (Figures 2A, 2B, and 2D) . A myc-tagged version of XFD was also do not function as dominant negatives for FGF-mediated processes (Amaya et al., 1993) . However, HAVφ and used, and cells expressing this construct were identified using the anti-myc antibody, 9E10 (Evan, et al., 1985) . XFD recently have been shown to act as dominant negative mutants for a non-FGF ligand of the FGFR, indicating
The FGFR mutants were expressed in large excess of levels of endogenous FGFR expression, and, therefore, that HAVφ may not always be a nonfunctional construct (Kinoshita et al., 1995) .
the cell bodies and axons of transfected neurons were easily identifiable over the background staining owing DNA constructs mixed with the lipofection agent DOTAP were injected into the proliferating neuroepithelto endogenous FGFR labeling (Figure 2 ; see Figure 5 ). At higher antibody concentrations, the endogenous ium that gives rise to the eye at embryonic stage 19, and the embryos were fixed ‫84ف‬ hr later at stage 40.
staining was evident (McFarlane et al., 1995) . When eye primordia were transfected with the domiBy stage 40, many RGC axons have grown out of the eye, into the brain, and innervated the optic tectum (Holt, nant negative FGFR, RGCs expressing XFD made up the same percentage of transfected retinal cells (16%, 1989) , and expression of the transfected genes are at their highest levels (Holt et al., 1990) . Embryos were n ϭ 417) as when retinal precursors were transfected with either of the two nonfunctional mutants, D48 (19%, n ϭ 168) or HAVφ (21%, n ϭ 476). RGCs were identified on the basis of morphology and laminar position. No XFD-transfected cells were obviously pycnotic, and XFD-expressing RGCs were observed as late as stage 45, 4 days after injection. These data suggest that FGF signaling is not required for specifying the identity of RGCs, for controlling their migration to the appropriate retinal laminae, or for their short-term survival. Almost all RGCs expressing the nonfunctional D48 or luciferase transgenes initiated axons (see Figure 2 ; Figure 3A ), many of which reached the optic tectum (D48, 47%, n ϭ 73; CS2-Luc, 50%, n ϭ 32) ( Figure 3C ). The majority of RGCs expressing the dominant negative, XFD (86%, 137/159), also sent out an axon; however, these axons were significantly shorter than those extended by RGCs expressing D48 or CS2-Luc (p<0.001, Kruskal-Wallis Nonparametric ANOVA Test) ( Figure 3B ). In fact, 44% (n ϭ 137) of mutant-expressing axons never exited the eye, and only a minority grew as far as the target region (13%, n ϭ 137) ( Figure 3C ). Similar results were observed with the myc-tagged version of XFD (data not shown). To address whether XFD-expressing axons that grew out to the target actually entered the optic tectum, we examined transfected axons in wholemount preparations. These data suggest that decreasing FGFR activity inhibits axon elongation in the optic pathway.
Surprisingly, only 37% (n ϭ 168) of RGCs expressing the HAVφ mutant sent out an axon ( Figure 3A ). Since almost all XFD-expressing RGCs extended axons, the HAVφ construct may interfere with axon initiation by blocking an FGF-independent process. The mean length of HAVφ axons was reduced slightly in comparison with control D48 and CS2-Luc axons ( Figure 3B ), reflecting a population of short axons in the optic pathway in the eye (29%, n ϭ 62) ( Figure 3C ). Interestingly, when we considered for each transgene the percentage of transfected axons that, having exited the eye, grew out to the target, over half of the HAVφ-expressing axons extended as far as the tectal area (56%, n ϭ 41), similar to the growth of RGC axons expressing the nonfunctional D48 (51%, n ϭ 67) and CS2-Luc (61%, n ϭ 26) transgenes. In contrast, only 24% (18/76) of XFD-expressing axons that exited the eye reached the target To address the possibility that the short length of (B) Average length of RGC axons transfected with each of the conthe dominant negative-expressing axons arises as an structs as measured from reconstruction of vibratome sections. Axon trajectories were localized in the optic pathway and plotted artifact owing to the failure of the XFD protein to be on a normalized brain to eliminate variability in brain size. In many transported to the axon tip, only the lengths of dominant retinae, several RGCs were transfected; therefore, it was often not negative-expressing axons with obvious growth cones possible to trace a given axon back to its cell body. As a result, were evaluated (61%, n ϭ 107), and a similar reduction showing that FGF-2 stimulates neurite extension of RGC whereas axons longer than 500 m (ϩ500) have reached the tectum. n is the number of axons.
axons in vitro (McFarlane et al., 1995) , the short length the speeds of untransfected RGC growth cones and RGC growth cones expressing either a myc-tagged version of the mutant XFD protein (XFD-myc) or green fluorescent protein (GFP) (or both) were measured in vitro. Eye primodia removed from stage 22 embryos were cotransfected with XFD-myc and GFP DNA, or transfected with GFP alone, and then cultured as explants for 48-72 hr. Prior to recording, the culture dishes were rinsed and incubated with L15 media and 0.1% bovine serum albumin. Growth cones were then recorded either with or without 20 ng/ml FGF-2, or with 20 ng/ml brainderived neurotrophic factor (BDNF). FGF-2 at this concentration stimulates retinal neurite outgrowth in dissociated eye cultures (McFarlane et al., 1995) , and BDNF promotes the survival of cultured Xenopus RGCs (Cohen-Cory and Fraser, 1994) . GFP-positive growth cones were followed with time-lapse videomicroscopy. After recording, we confirmed that these growth cones were XFD-positive by immunolabeling with anti-myc (see Figures 4A and 4B) .
In the presence of FGF-2, RGC axons with impaired FGFR activity grew at 38 m/hr, ‫%06ف‬ of the speed of untransfected or GFP-only-expressing axons ( Figures  4C and 4D ). In the absence of FGF-2, all growth cones grew at a similarly reduced speed ( Figure 4D ). Because XFD had no effect on outgrowth stimulated by BDNF ( Figure 4D ), a growth factor that works through dimerization of trk B, it is unlikely that this mutant FGFR is inhibiting axon extension or growth factor RTK signaling in a nonspecific manner. The demonstration that XFD can specifically inhibit FGF-stimulated events, but has no effect on BDNF-stimulated outgrowth, is important as it indicates that XFD can act as a dominant negative FGFR in Xenopus retinal neurons. Half of the XFD-mycexpressing growth cones (10/20) in FGF-2 grew at a In of XFD-expressing retinal axons supports the idea that the eye, the axons grow across the vitreal surface, exsignaling through the FGFR promotes extension of optic tend into the optic nerve head, and exit via the optic axons in the pathway.
nerve. In the brain, axons cross the midline at the optic chiasm, grow dorsally, and, midway through the diencephalon, turn caudally and grow towards the optic tecDecreasing FGFR Function Slows Down RGC Growth Cones tum (Holt, 1989) . To examine whether axonal FGFRs are required for pathfinding in the retina and the optic tract, An alternative explanation for shortened XFD-expressing axons is that inhibiting FGFRs in RGCs delays axon transfected RGC axons were visualized at stage 40 in serial vibratome sections, and in wholemount brains initiation. To directly measure the rate of axon growth, . Axons expressing the luciferase reporter construct make a caudal turn in the mid-diencephalon (Di) and grow into the tectum where they stop and arborize. The axon with impaired FGFR signaling in (B) is able to pathfind correctly, making the turn in the mid-diencephalon. This axon appears to branch prematurely in the ventral diencephalon (B and E). While some axons expressing the dominant negative FGFR enter the tectum (see Figure 6 ), others veer aberrantly near the tectal border and grow dorsally (E) or ventrally (F) around the tectum. D, dorsal; V, ventral; Pi, pineal; Di, diencephalon; Tec, tectum. Scale bar, 100 m for (A)-(B); 40 m for (C)-(F).
with respect to specific brain landmarks (see Figure 2 ;
Since the onset of XFD expression may vary with respect to the time of process initiation and outgrowth, it is Figure 5 ). The majority of XFD-expressing retinal axons exhibited normal pathfinding, as did all the axons possible that axons showing normal pathfinding are not yet expressing significant levels of the mutant protein. transfected with control constructs. A few axons (<10%) expressing the dominant negative FGFR showed pathGiven the number of pathway choices these axons encounter, however, the very low number of pathfinding finding errors, growing dorsally rather than ventrally in the eye (n ϭ 9), abruptly changing direction in the optic errors suggests that FGFRs are not required for retinal axons to select the correct path. tract (n ϭ 3), or growing very anteriorly in the diencephalon (n ϭ 12). The number of cases for each pathfinding Newly extended RGC axons occasionally bifurcate within, but rarely outside, the retina (Holt, 1989) . This defect is small, but no similar behaviors were observed for axons transfected with any of the control constructs.
was the case for axons transfected with the luciferase sections, whereas for HAVφ and D48 these axons represented ‫%04ف‬ and 50% of the populations respectively. Figure 5 and Figure 6 show examples of the behavior of axons expressing the various transgenes as they reach the tectum. We used three reliable morphological landmarks to identify the anterior border of the tectum: the point where the second ventricle enlarges into the third, the posterior border of the neuropil of the tract of the posterior commissure, and the position of the dorsolateral isthmus between the diencephalon and midbrain (see dotted lines in Figure 5 and Figure 6 ). Almost all the axons reaching the target and expressing control luciferase, HAVφ, or D48 constructs entered and arborized in the tectum ( Figure 6E ). In contrast, inhibiting FGFR activity with XFD caused many axons (41%, n ϭ 126) to fail to innervate the target ( Figure 6E intensity; axons were assigned a value on a scale of 1-3 (1 corresponded to faintly stained axons and 3 to darkly stained axons). When the behavior of the most darkly (4/109) or nonfunctional D48 (3/41) constructs. In conlabeled axons was considered, presumably correspondtrast, a significant number of axons expressing the XFD ing to the highest levels of XFD protein expression, over mutant protein bifurcated either in the optic tract (Figure half were short and had not yet reached the target (31/ 5B) or close to the tectal border (33%, 42/126) ( Figure  57 ). For the remaining intensely labeled axons that had 6D). While it is possible that branching could be grown as far as the tectum and made a targeting decimistaken for defasciculation of two axons, abnormal sion (n ϭ 26), a mistargeting phenotype was seen in branching was seen in cases where XFD-expressing 73% of the cases. axons could be traced back to individual RGC cell bodies. This was not true of axons expressing one of the control transgenes. One explanation for the aberrant Discussion branching is that a premature decrease in FGFR signaling may mimic the decrease in FGF-2 at the tract/tectal
In this study, we demonstrate that the FGFR is one juncture and thus initiate branching/arborization behavof the receptors in RGC growth cones that transduces ior normally seen only in the optic tectum.
environmental cues required for the formation of the retinotectal projection. A mutant FGFR that blocks the function of endogenous FGFRs was used in vivo to show Retinal Axons Expressing the Dominant Negative FGFR Fail to Enter the Tectum the importance of retinal growth cone FGFR signaling both for normal extension in the optic pathway and tarThe finding that exogenously applied FGF-2 causes RGC axons to ignore their target raises the possibility get recognition. Axons need cues that tell them to grow, steer, and that FGFRs play a role in the selection of and entry into the tectum (McFarlane et al., 1995) . Therefore, we stop once they arrive at their target. Our data indicate that in the developing Xenopus visual system signaling analyzed in wholemount the behavior of axons that had extended as far as the tectum at the time of fixation. through the FGFR is involved in two of these processes: extension and target recognition. Previously, we For XFD-expressing axons, this represented a small percentage (15%) of the entire population of axons as detershowed that FGF-2 stimulates retinal neurite extension in vitro and causes mistargeting of retinal axons when mined from the aforementioned analysis of vibratome applied exogenously to the developing optic projection phenotype. One simple interpretation for the similar phenotypes, based on data showing that FGFs can inhibit (McFarlane et al., 1995) . The transfection experiments presented in the present study provide direct evidence FGFR activity (Williams et al., 1995) , is that FGFR signaling is impaired in both cases. However, our data support for an in vivo role for FGFRs in neuronal connectivity. The abnormally short length of XFD-expressing axons the idea that exogenous FGF-2 activates the FGFR; FGF-2 causes target recognition errors in vivo at consuggests that FGFR signaling is normally involved in the extension of RGC axons along the optic pathway. FGF-2 centrations that cause stimulation of retinal neurite extension in vitro (McFarlane et al., 1995) , and unlike XFDis a candidate growth-promoting ligand for the receptor based on its presence in the developing optic tract and expressing axons, FGF-2-treated axons in vivo show no defects in extension, and, in fact, grow further than on its stimulation of retinal neurite extension in culture (McFarlane et al., 1995) . Indeed, we show that inhibiting normal. Thus, it seems that mistargeting can result from either growth cone FGFR activity decreases FGF-2-stimulated, but not BDNF-stimulated, retinal neurite outa sustained increase or decrease in FGFR activity. This leads to a model based on the idea that retinal growth growth in vitro to a degree that is similar to axons growing in the absence of FGF-2 ligand (McFarlane et al., cones recognize their target in part by responding to changes in FGFR signaling that occur at the tectal bor-1995). A reduction in growth rate owing to a loss of an FGF signal could explain the short length of domider. There are several ways that FGFR signaling could be altered: first, a change in FGF concentration, such nant negative-expressing axons observed in vivo. While FGFs are known to stimulate neurite outgrowth in culture as a drop in FGF-2 levels at the tract/tectal juncture; second, a switch to a new FGFR ligand; and third, a (Hatten, et al., 1988; Lipton et al., 1988; Rydel and Greene, 1987; Walicke et al., 1986; Walicke, 1988) , our new HS cofactor altering the activity of the high-affinity FGF RTK. Since our previous work is consistent with current data indicate that in vivo, signaling via FGFRs promotes axon extension. Despite their slower growth the notion that FGF and HS levels drop at the target (McFarlane et al., 1995; A. Walz, unpublished data) , we rates, almost all axons whose FGFRs are inhibited make appropriate pathfinding decisions and grow within the favor the idea that a change in FGF signaling notifies axons that they have arrived at their target by slowing optic tract. It is only when they near the target that aberrant behavior is exhibited, with many of the axons their advancement and switches them from a growing mode into an arborizing mode. Indeed, in vivo timenot entering the tectum but turning abruptly and skirting its dorsal or ventral borders. That FGF signaling plays lapse microscopy indicates that Xenopus RGC axons slow down and alter their behavior dramatically upon no significant role in axon pathfinding is supported by the fact that bathing the entire brain with exogenous reaching the tectum (Harris et al., 1987) . The similar phenotypes observed for exogenous FGF-2 application FGF-2, which presumably eliminates regional differences in FGF-2 levels, has no effect on the steering of and dominant negative inhibition of RGC FGFR activity argue that it is a rate change, not simply slowed growth, axons in the optic tract (McFarlane et al., 1995) .
The mistargeting of retinal axons exposed to exogethat is requisite for axonal targeting. In both cases, axons are impaired in their ability to register a FGF concennously applied FGF-2 has implicated FGFR signaling in target recognition (McFarlane et al., 1995) . This previous tration difference, either because the difference is swamped by exogenous FGF-2 or not registered when study, however, did not address whether FGFR activity is involved normally in target recognition, nor whether FGFRs in RGC axons are inhibited by overexpression of XFD. Thus, although the axons grow at different axon misrouting was caused indirectly by FGF-2-induced changes to the neuroepithelium. The mistarspeeds, in neither situation do they alter their growth rate on nearing the tectum, and consequently fail to geting of XFD-expressing axons provides good evidence that axonal FGFRs play an endogenous role in switch from a growing mode. As a result, oblivious to their normal target, the retinal axons continue extending target recognition. Further, several pieces of data point to an FGF as the ligand involved. First, exogenous FGF-2 inappropriately within growth stimulatory regions anterior and ventral to their normal target. Previously, others causes axon mistargeting, as do FGF-2-binding but not FGF-1-binding brain-derived heparan sulfates (HSs) have postulated that changes in growth factor levels upon reaching the target are important for normal in- (Nurcombe et al., 1993; A. Walz, unpublished data) . Second, axons expressing HAVφ, a mutant FGFR shown nervation (Hoyle et al., 1993; Zhang et al., 1994; ElShamy et al., 1996) . For instance, the innervation of PNS targets to be incapable of inhibiting FGF-dependent signaling (Amaya et al., 1993) , enter the tectum normally. The by sympathetic axons depends on growth cones being able to register a nerve growth factor (NGF) concentra-FGF-2 expression pattern (McFarlane, et al., 1995) and the mistargeting caused specifically by FGF-2-binding tion difference at the target (Hoyle et al., 1993) . Sympathetic axons transgenically altered to express and seHSs (A. Walz, unpublished data) are suggestive of a particular role for FGF-2 in axonal targeting. Interestcrete NGF fail to innervate their unmodified targets, presumably because the growth cones exposed to exingly, FGF-3 and eFGF mRNAs are expressed in the posterior tectum, raising the possibility that a posterior cess NGF are blinded to endogenous gradients. That innervation can be restored if a target is made to overexto anterior difference of either FGF in the tectum could function in target recognition (Tannahill et al., 1992;  press NGF supports this idea. In contrast with the strong penetrance of the mistar- Isaacs et al., 1995) . Any explanation of how FGFs are involved in target recognition must take into account geting phenotype produced by exogenous application of FGF-2, many of the axons with impaired FGFR functhat both providing exogenous ligand and inhibiting receptor activity results in the same aberrant targeting tion that reach the tectum target correctly. Innervation may simply reflect insufficient XFD inhibition of FGFR instance, the lack of influence of the HAVφ protein on axon entry into the tectum, in addition to the mistaractivity at the time those axons are reaching the target.
geting caused by exogenous FGF-2 and FGF-2 binding Indeed, only 30% of the most highly immunolabeled HSs, implicates FGF signaling in target recognition. In axons enter the tectum. Alternatively, given the probable comparison, the inhibition of axonogenesis observed redundancy of cues involved in target recognition, it only with HAVφ indicates that axon initiation and extenmay not be surprising that many XFD-expressing axons sion within the eye is not an FGF-dependent process. innervate the target. Recently, it has been argued that The ability of both XFD and HAVφ to inhibit axon extenremoval of a single target recognition cue from a populasion within the eye raises the interesting possibility that tion of organized signals may be a less effective stimulus several ligands act via the same receptor to promote than the ectopic disorganized overexpression of that axon growth. Why XFD does not similarly inhibit axon same protein (Nose et al., 1994; Chiba et al., 1995) . In initiation is puzzling, but may reflect some critical funcDrosophila, the phenotype of a genetic knockout of a tion of the HAVφ sequence. The importance of the HAV single protein involved in axon guidance or target recogsequence for protein-protein interactions may hint at a nition (or both) is often not fully penetrant (Nose et al., mechanism; the HAV domain has been postulated to 1994; Lin and Goodman, 1994; Desai, et al., 1996) . This mediate homophilic interactions between cadherin molargues for redundancy in the signaling mechanisms and ecules (Blaschuk et al., 1990) and heterophilic interacindicates that other molecules, in addition to FGFRs, tions between the FGFR and both cadherin (Williams et are important for target recognition.
al., 1994) and heparin (Byers et al., 1992) . Regardless XFD is thought to exert its effects by forming nonfuncof the actual ligand(s), our data strongly suggest that tional heterodimers with endogenous FGFRs in re-FGF RTKs play a role in vivo in RGC axon extension and sponse to ligand binding (Amaya et al., 1991 (Amaya et al., , 1993 , and target recognition. In the future, it will be interesting to functions in Xenopus embryos as a dominant negative determine the link that the FGFR makes between spefor FGFR involvement in both mesodermal and neural cific extracellular signals and the intracellular mechainduction (Amaya et al., 1991 (Amaya et al., , 1993 Launay et al., 1996) . nisms of axon growth and guidance. The specific inhibition of FGF-stimulated, but not BDNFstimulated, neurite extension in retinal explant cultures
Experimental Procedures
suggests that XFD similarly is acting as a dominant negative in the Xenopus retinal system. As has been demonAnimals strated for chick (Ueno et al., 1992) , XFD is probably Embryos were attained by fertilizing eggs obtained from adult female capable of inhibiting all of the wild-type Xenopus FGFRs, X. laevis injected with human chorionic gonadotropin. Embryos were kept in 10% Holtfreter's solution (Holtfreter, 1943) with the temperaof which three FGFR families have been cloned (Musci ture varied between 14ЊC and 27ЊC to control their speed of developet al., 1990; Friesel and Dawid, 1991; Friesel and Brown, ment . Embryos were staged according to Nieuwkoop and Faber 1992; Shiozaki et al., 1995; Riou et al., 1996) . Messenger (1967) . For DNA injections, embryos were anaesthetized in Modified RNAs for both FGFR-1 and FGFR-2 are expressed in Barth's Saline (88 mM NaCl, 1 mM KCl, 0.7 mM CaCl2, 1mM MgS04, developing chick RGCs (Tcheng et al., 1994) , and (Lilienbaum et al., 1995) . In brief, embryos were incubated in primary to reduce illumination intensity. GFP-positive growth cones were recorded for 30-90 min using a Cohu 4915 video camera at 48ϫ antibody overnight, rinsed, and then incubated in secondary antibody overnight. Antibody-treated embryos were incubated in 0.5% time-lapse with a Mitsubishi HS-55600 SVHS time-lapse VCR. After recording, cultures were fixed in 4% paraformaldehyde for 1 hr at diaminobenzidine (Sigma) for 30 min at which point 1% hydrogen peroxide was added to catalyze the peroxidase reaction. Embryos room temperature, left overnight in methanol at Ϫ20ЊC, immunostained for c-myc, and viewed with the inverted microscope under were post-fixed for 1 hr in 1% gluteraldehyde at room temperature and processed as wholemounts, or embedded in gelatin-albumin, epifluoresence to confirm the coexpression of XFD and GFP. For analysis, length measurements were taken from the video screen and 50 m vibratome-sections were cut (Oxford). Wholemount brains and vibratome sections were dehydrated through a series of at 5 min intervals and processed using Excel (Microsoft). alcohols. Vibratome sections were additionally cleared in Xylene and mounted under a glass coverslip with Permount (Fisher Scientific Acknowledgments Company, Pittsburgh, PA). Wholemount brains were cleared in 2:1 benzyl benzoate:benzyl alcohol and mounted in permount with two
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